Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW 5,260.00
+810.00 (18.20%)
At close: Dec 5, 2025
89.89% (1Y)
| Market Cap | 163.51B |
| Revenue (ttm) | 25.95B |
| Net Income (ttm) | -27.82B |
| Shares Out | 31.09M |
| EPS (ttm) | -693.54 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,959,947 |
| Average Volume | 1,338,952 |
| Open | 4,360.00 |
| Previous Close | 4,450.00 |
| Day's Range | 4,295.00 - 5,550.00 |
| 52-Week Range | 2,170.00 - 5,550.00 |
| Beta | 0.79 |
| RSI | 81.76 |
| Earnings Date | Nov 14, 2025 |